VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹315 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹315 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹137 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹315 Cr | 12.61 | |
| Mar2024 | ₹280 Cr | 16.58 | |
| Mar2023 | ₹240 Cr | 29.66 | |
| Mar2022 | ₹185 Cr | 35.66 | |
| Mar2021 | ₹137 Cr | - | |
Compare Net Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,003.7 Cr | -2.8% | 59.7% | 136.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,170.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,038.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,357.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,414.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,015.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2.8% |
59.7% |
136.3% |
| SENSEX | -0.6% |
1.7% |
4.6% |
You may also like the below Video Courses